Abstract
The Swedish STRIDA project on new psychoactive substances (NPS) monitored the occurrence and health hazards of novel recreational drugs in Sweden through evaluation of analytically confirmed adverse events presenting in emergency departments and intensive care units. During a ~6-year period from 2010 to early 2016, about 2,600 cases of suspected NPS intoxications were included in the project. About 75% of patients were men and the total age range was 8–71 (median 24) years and 57% were 25 years or younger. A large number of NPS belonging to many different drug classes were identified in project samples of urine and blood (serum/plasma) submitted for free drug testing, including synthetic cannabinoid receptor agonists, stimulants, cathinones, hallucinogens, dissociative drugs, benzodiazepines, and opioids, and also in drug materials from the cases forwarded to the laboratory along with the biological samples. The STRIDA project has been shown to serve as an effective early warning system for NPS by collecting data on incidence, distribution, and adverse effects and has supported healthcare professionals in the knowledge and critical care of intoxications caused by a wide range of novel substances. The results of the STRIDA project have also illustrated how drug regulations can drive the NPS market.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Saffar Y, Stephanson NN, Beck O (2013) Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 930:112–120
Auwärter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N (2009) ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837
Bäckberg M, Beck O, Hulten P, Rosengren-Holmberg J, Helander A (2014) Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): a case series from the Swedish STRIDA project. Clin Toxicol (Phila) 52:618–624
Bäckberg M, Beck O, Helander A (2015a) Phencyclidine analog use in Sweden – intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clin Toxicol (Phila) 53:856–864
Bäckberg M, Beck O, Jönsson KH, Helander A (2015b) Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin Toxicol (Phila) 53:609–617
Bäckberg M, Lindeman E, Beck O, Helander A (2015c) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 53:46–53
Bäckberg M, Westerbergh J, Beck O, Helander A (2016) Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project. Clin Toxicol (Phila) 54:819–825
Bäckberg M, Tworek L, Beck O, Helander A (2017) Analytically confirmed intoxications involving MDMB-CHMICA from the STRIDA project. J Med Toxicol 13:52–60
Bäckberg M, Jönsson KH, Beck O, Helander A (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Test Anal 10:340–349
Baron M, Elie M, Elie L (2011) An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 3:576–581
Beck O, Franzen L, Bäckberg M, Signell P, Helander A (2015) Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila) 53:865–873
Beck O, Franzen L, Bäckberg M, Signell P, Helander A (2016) Toxicity evaluation of alpha-pyrrolidinovalerophenone (alpha-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila) 54:568–575
Björnstad K, Beck O, Helander A (2009) A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B Analyt Technol Biomed Life Sci 877:1162–1168
Bradley M, Hasselblad A, Norlen L, Lapins J, Bäckberg M, Helander A (2016) Acute cutaneous symptom complex with subsequent cataract. The internet drug MT-45 may be the cause. Lakartidningen 113. DTAF
Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI (2010) Purchasing ‘legal highs’ on the internet – is there consistency in what you get? QJM 103:489–493
Drug Enforcement Administration (2016) Counterfeit prescription pills containing fentanyls: a global threat. https://www.dea.gov/docs/Counterfeit%20Prescription%20Pills.pdf
EMCDDA (2009) Understanding the ‘Spice’ phenomenon. http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_EMCDDA_Understanding%20the%20%E2%80%98Spice%E2%80%99%20phenomenon_4Update%2020090813.pdf
EMCDDA (2017) European drug report 2017: trends and developments. http://www.emcdda.europa.eu/system/files/publications/4541/TDAT17001ENN.pdf
Gladden RM, Martinez P, Seth P (2016) Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths – 27 states, 2013–2014. MMWR Morb Mortal Wkly Rep 65:837–843
Helander A, Bäckberg M (2016) New Psychoactive Substances (NPS) – the Hydra monster of recreational drugs. Clin Toxicol (Phila) 55(1):1–3
Helander A, Beck O, Hägerkvist R, Hulten P (2013) Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scand J Clin Lab Invest 73:400–406
Helander A, Bäckberg M, Beck O (2014a) MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 52:901–904
Helander A, Bäckberg M, Hulten P, Al-Saffar Y, Beck O (2014b) Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int 243:23–29
Helander A, Beck O, Bäckberg M (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol (Phila) 53:446–453
Helander A, Bäckberg M, Beck O (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila) 54:324–332
Helander A, Bradley M, Hasselblad A, Norlen L, Vassilaki I, Bäckberg M, Lapins J (2017a) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. Br J Dermatol 176:1021–1027
Helander A, Bäckberg M, Signell P, Beck O (2017b) Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project. Clin Toxicol (Phila) 55:589–599
Johansson M, Fransson D, Rundlof T, Huynh NH, Arvidsson T (2014) A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 100:215–229
Kamijo Y, Takai M, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S, Yokoyama T, Yagi K, Sakamoto T (2014) A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med 53:2439–2445
Lindeman E, Hulten P, Ström S, Enlund M, Al-Saffar Y, Helander A (2012) Ökat missbruk av Internetdrogen MDPV i Västmanland. Svåra förgiftningsfall har gett sjukvården stora problem. Lakartidningen 109:1954–1957
Lindeman E, Bäckberg M, Personne M, Helander A (2014) MT-45 – a dangerous and potentially ototoxic internet drug. Lakartidningen 111:1712–1715
Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58–63
Marriott KS, Huffman JW (2008) Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr Top Med Chem 8:187–204
Meyer MR, Pettersson Bergstrand M, Helander A, Beck O (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Anal Bioanal Chem 408:3571–3591
Ojanperä I, Kriikku P, Vuori E (2016) Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med 130:1209–1216
Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J (1998) Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 36:205–213
Pettersson Bergstrand M, Helander A, Hansson T, Beck O (2017a) Detectability of designer benzodiazepines in CEDIA, EMIT II plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal 9:640–645
Pettersson Bergstrand M, Meyer MR, Beck O, Helander A (2017b) Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Drug Test Anal 10:496–506
Simonsen KW, Edvardsen HM, Thelander G, Ojanperä I, Thordardottir S, Andersen LV, Kriikku P, Vindenes V, Christoffersen D, Delaveris GJ, Frost J (2015) Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 248:172–180
Starmark JE, Stålhammar D, Holmgren E, Rosander B (1988) A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 69:699–706
Stephanson NN, Signell P, Helander A, Beck O (2017) Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing – a step towards a ‘black-box’ solution? J Mass Spectrom 52:497–506
UNODC (2017) Fentanyl and its analogues – 50 years on. https://www.unodc.org/documents/scientific/Global_SMART_Update_17_web.pdf
WHO (2014) Community management of opioid overdose. http://apps.who.int/iris/bitstream/10665/137462/1/9789241548816_eng.pdf?ua=1&ua=1
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Helander, A., Bäckberg, M. (2018). Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project. In: Maurer, H., Brandt, S. (eds) New Psychoactive Substances . Handbook of Experimental Pharmacology, vol 252. Springer, Cham. https://doi.org/10.1007/164_2018_134
Download citation
DOI: https://doi.org/10.1007/164_2018_134
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10560-0
Online ISBN: 978-3-030-10561-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)